Anne-Laure Michon

486 total citations
21 papers, 296 citations indexed

About

Anne-Laure Michon is a scholar working on Epidemiology, Endocrinology and Clinical Biochemistry. According to data from OpenAlex, Anne-Laure Michon has authored 21 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Endocrinology and 6 papers in Clinical Biochemistry. Recurrent topics in Anne-Laure Michon's work include Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Infections and bacterial resistance (4 papers). Anne-Laure Michon is often cited by papers focused on Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Infections and bacterial resistance (4 papers). Anne-Laure Michon collaborates with scholars based in France, Djibouti and Chile. Anne-Laure Michon's co-authors include Hélène Marchandin, Estelle Jumas‐Bilak, R. Chiron, Chloé Dupont, Fabien Aujoulat, Hélène Jean‐Pierre, Éric Jeziorski, Anne Filleron, M. Rodière and Brigitte Lamy and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Journal of Clinical Microbiology.

In The Last Decade

Anne-Laure Michon

21 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne-Laure Michon France 11 80 78 72 66 55 21 296
R Yousefi Mashouf Iran 10 116 1.4× 55 0.7× 102 1.4× 70 1.1× 75 1.4× 42 376
Tatiana Travis United States 7 144 1.8× 30 0.4× 105 1.5× 95 1.4× 135 2.5× 7 352
Tsong-Yih Ou Taiwan 11 119 1.5× 66 0.8× 61 0.8× 135 2.0× 119 2.2× 21 352
Jolanta Kędzierska Poland 11 99 1.2× 37 0.5× 52 0.7× 38 0.6× 153 2.8× 21 315
Teck Wee Boo Ireland 11 112 1.4× 23 0.3× 94 1.3× 68 1.0× 62 1.1× 12 304
Zeynep Şenses Türkiye 10 51 0.6× 37 0.5× 78 1.1× 83 1.3× 79 1.4× 21 346
James S. Cargill United Kingdom 6 81 1.0× 39 0.5× 56 0.8× 20 0.3× 85 1.5× 8 223
Kiyoshi Negayama Japan 11 92 1.1× 39 0.5× 84 1.2× 95 1.4× 75 1.4× 30 343
Anne Kjerulf Denmark 11 104 1.3× 53 0.7× 70 1.0× 54 0.8× 149 2.7× 24 360
Margot E. Grinwis Canada 7 98 1.2× 93 1.2× 175 2.4× 29 0.4× 66 1.2× 7 350

Countries citing papers authored by Anne-Laure Michon

Since Specialization
Citations

This map shows the geographic impact of Anne-Laure Michon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Laure Michon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Laure Michon more than expected).

Fields of papers citing papers by Anne-Laure Michon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Laure Michon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Laure Michon. The network helps show where Anne-Laure Michon may publish in the future.

Co-authorship network of co-authors of Anne-Laure Michon

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Laure Michon. A scholar is included among the top collaborators of Anne-Laure Michon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Laure Michon. Anne-Laure Michon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galal, Lokman, Juliette Hayer, Julio A. Benavides, et al.. (2023). Genomic epidemiology of carbapenemase-producing Gram-negative bacteria at the human-animal-environment interface in Djibouti city, Djibouti. The Science of The Total Environment. 905. 167160–167160. 5 indexed citations
2.
Bessède, Thomas, Pauline Mayonove, Hung‐Ju Chang, et al.. (2023). An optimized electrotransformation protocol for Lactobacillus jensenii. PLoS ONE. 18(2). e0280935–e0280935. 1 indexed citations
3.
Marin, Grégory, Anne Filleron, Anne-Laure Michon, et al.. (2022). Evaluation of post-infectious inflammatory reactions in a retrospective study of 3 common invasive bacterial infections in pediatrics. Medicine. 101(38). e30506–e30506. 4 indexed citations
4.
Dumont, Yann, Anne-Laure Michon, Christian Carrière, et al.. (2020). Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals. Anaerobe. 64. 102207–102207. 16 indexed citations
5.
Dupont, Chloé, et al.. (2019). Streptococcus pseudopneumoniae, an opportunistic pathogen in patients with cystic fibrosis. Journal of Cystic Fibrosis. 19(4). e28–e31. 14 indexed citations
6.
Filleron, Anne, Grégory Marin, Hélène Marchandin, et al.. (2019). Short-course antibiotic treatment of bone and joint infections in children: a retrospective study at Montpellier University Hospital from 2009 to 2013. Journal of Antimicrobial Chemotherapy. 74(12). 3579–3587. 17 indexed citations
7.
Dumont, Yann, et al.. (2018). Rôle du laboratoire de biologie médicale dans le diagnostic microbiologique des bactéries anaérobies. Revue Francophone des Laboratoires. 2018(505). 40–47. 1 indexed citations
8.
Romano-Bertrand, Sara, Fabien Aujoulat, Anne-Laure Michon, et al.. (2016). Skin microbiota is the main reservoir of Roseomonas mucosa , an emerging opportunistic pathogen so far assumed to be environmental. Clinical Microbiology and Infection. 22(8). 737.e1–737.e7. 38 indexed citations
9.
10.
Dupont, Chloé, Estelle Jumas‐Bilak, Anne-Laure Michon, R. Chiron, & Hélène Marchandin. (2016). Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing. Journal of Clinical Microbiology. 55(1). 206–215. 14 indexed citations
11.
Filleron, Anne, Anne-Laure Michon, Estelle Jumas‐Bilak, et al.. (2015). What to expect from molecular tools for non-documented pediatric infectious diseases. Expert Review of Molecular Diagnostics. 15(12). 1645–1656. 3 indexed citations
12.
Dupont, Chloé, Anne-Laure Michon, Estelle Jumas‐Bilak, et al.. (2015). Intrapatient diversity of Achromobacter spp. involved in chronic colonization of Cystic Fibrosis airways. Infection Genetics and Evolution. 32. 214–223. 29 indexed citations
13.
Michon, Anne-Laure, Estelle Jumas‐Bilak, R. Chiron, Brigitte Lamy, & Hélène Marchandin. (2014). Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients. PLoS ONE. 9(2). e90164–e90164. 31 indexed citations
14.
Michon, Anne-Laure. (2014). Une mission de recherche-action pour réduire le non-recours aux minima sociaux. N° 46(2). 129–134. 1 indexed citations
16.
Michon, Anne-Laure, et al.. (2013). Bacteremia Due to Imipenem-resistant Roseomonas mucosa in a Child With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 36(3). e165–e168. 14 indexed citations
17.
Filleron, Anne, Éric Jeziorski, Anne-Laure Michon, M. Rodière, & Hélène Marchandin. (2012). Current insights in invasive group A streptococcal infections in pediatrics. European Journal of Pediatrics. 171(11). 1589–1598. 25 indexed citations
18.
Michon, Anne-Laure, et al.. (2012). Clinical and Antimicrobial Susceptibility Data of 140 Streptococcus pseudopneumoniae Isolates in France. Antimicrobial Agents and Chemotherapy. 56(8). 4504–4507. 25 indexed citations
20.
Michon, Anne-Laure, et al.. (2010). Intragenomic and intraspecific heterogeneity in rrs may surpass interspecific variability in a natural population of Veillonella. Microbiology. 156(7). 2080–2091. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026